Kestra Advisory Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
KWM
FCBT
EP
Kestra Advisory Services's XPH Position: Q2 2026 in Review
Kestra Advisory Services reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 68% in Q2 2026, selling an estimated $460K and leaving 3,757 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.
Kestra Advisory Services first reported a position in XPH in Q4 2020 and has held it in 5 quarters since. The position peaked at $1.54M in Q4 2020. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.
- Kestra Advisory Services held 3,757 shares of State Street SPDR S&P Pharmaceuticals ETF worth $249K as of Q2 2026.
- Kestra Advisory Services sold 7,846 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $460K.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2932 holding.
- Kestra Advisory Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2020 and has held it in 5 quarters since.
- Kestra Advisory Services's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.54M in Q4 2020.
- 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.
Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.